Showing results (71-80 of 185) with videos related to
Sort By:
Pageof 19
Molecular and Cellular Endocrinology|April 25, 2000
Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patientsD Canale, E Vignali, F Golia, et al.Journal of Endocrinological Investigation|February 27, 2003
Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?L Bartalena, C Marcocci, C A Gorman, et al.La Radiologia Medica|April 1, 1990
[CT of the orbit in Graves' ophthalmopathy]P Bagnolesi, A Cilotti, L Bartalena, et al.The New England Journal of Medicine|November 16, 1989
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidismL Bartalena, C Marcocci, F Bogazzi, et al.The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptorsP Rodien, F Cetani, S Costagliola, et al.Molecular and Cellular Endocrinology|May 31, 1996
Specific activation of the thyrotropin receptor by trypsinJ Van Sande, C Massart, S Costagliola, et al.Journal of Endocrinological Investigation|May 29, 2004
Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisitedM Marinò, L Chiovato, S Lisi, et al.Journal of Endocrinological Investigation|November 1, 1991
Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized studyC Marcocci, L Bartalena, F Bogazzi, et al.Journal of Endocrinological Investigation|February 26, 2008
Kidney abnormalities in low density lipoprotein receptor associated protein knockout miceS Lisi, R Botta, A Pinchera, et al.World Journal of Surgery|July 1, 1994
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodineF Pacini, F Cetani, P Miccoli, et al.Pageof 19